healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.
By ‘red-flagging’ prescriptions that come from telehealth providers in other states, the proposed DEA rules may “inadvertently create barriers to care,” said Joseph Kvedar, MD. In this piece, he discusses recommendations from the ATA to help build pharmacists’ trust in filling remote prescriptions.
For cybersecurity leaders, learning “how to foster innovation while ensuring robust defenses against ever-evolving threats” has become quite the dilemma, according to Dennis Leber. In this piece, he identifies the key threats and shares advice on how to mitigate them.
Telehealth has come a long way since the Covid-induced boom, but a lot hinges on its continued success, according to Joseph Kvedar, MD. In this piece, he examines the impact it has had, the vision for what telehealth can be, and the steps organizations can take to get there.
With the public health emergency scheduled to expire, the DEA has proposed rules that put patients at risk of “not getting critical, clinically appropriate medications, which in turn puts their lives at risk,” said Dr. Joseph Kvedar. In this blog, he provides information on how leaders can get involved and help prevent a “potential public health crisis.”
Despite the fact that CMS has extended the public health emergency that expanded telemedicine coverage, a number of states aren’t on board, according to Dr. John Halamka and Paul Cerrato. “Finding a way to extend the regulatory waivers,” they write, “is in our patients’ best interest.”
Although there are myriad challenges with incorporating tools like machine learning into care environment, the upside is simply too promising to pass up, said John Halamka, MD, during a healthcare IT policy discussion. “There’s a perfect storm happening.”
As the viability of long-term telehealth reimbursement continues to hang in the balance, how can healthcare organizations prepare? What can leaders reasonably expect? Joe Kvedar, MD, shares his thoughts.
With one major milestone of the interoperability rule checked off and another approaching quickly, it’s time for leaders to “take the reins and turn these rules into actionable insights for clinicians and patients,” according to John Halamka, MD, and Paul Cerrato of Mayo Clinic Platform.
Despite the unfortunate timing of being released right as COVID-19 reached pandemic status, the final rule on interoperability and patient access is a significant step for the industry, says Michael Lipinski of ONC.
Forget what you think you know about platforms. What it’s really about, says Dr. John Halamka, is creating “a single, managed and well supported front door which enables quality, safety and efficiency solutions to be deployed more quickly.”
